Literature DB >> 7417523

Relationship between bone resorption and lysosomal enzyme release as demonstrated by the effect of 1 alpha-hydroxy-vitamin D-3 in an organ culture system.

U Lerner.   

Abstract

The effect of 1 alpha-hydroxy-vitamin D-3 on the release of calcium (40Ca, 45Ca), inorganic phosphate and lysosomal enzymes, on glucose consumption and lactate production was studied in a bone organ culture system using half calvaria from 6--7-day-old mice. 1 alpha-Hydroxy-vitamin D-3 stimulated the mobilization of minerals and increased the release of beta-glucuronidase, beta-N-acetylglucosaminidase and acid phosphatase, while no effect on the release of lactate dehydrogenase was seen. 1 alpha-Hydroxy-vitamin D-3 also caused a significant increase in the total activities of acid phosphatase in the bones after culture, indicating increased enzyme synthesis. The stimulatory effect on the release of Pi and beta-glucuronidase was also obtained after a temporary exposure to 1 alpha-hydroxy-vitamin D-3. The stimulation by 1 alpha-hydroxy-vitamin D-3 on the release of Ca2+, Pi and beta-glucuronidase was suppressed by a protein synthesis inhibitor, cycloheximide. No effect by 1 alpha-hydroxy-vitamin D-3 on glucose consumption and lactate production was registered, suggesting that increased mineral mobilization does not require increased lactate production. It is concluded that although the data in the present paper do not prove a cause-and-effect relationship between lysosomal enzyme release and bone resorption, they give further support to the concept that the processes are intimately associated.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7417523     DOI: 10.1016/0304-4165(80)90078-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Prostaglandin E2 causes a transient inhibition of mineral mobilization, matrix degradation, and lysosomal enzyme release from mouse calvarial bones in vitro.

Authors:  U H Lerner; M Ransjö; O Ljunggren
Journal:  Calcif Tissue Int       Date:  1987-06       Impact factor: 4.333

2.  Impaired bone resorption of cultured calvaria from mice with abnormal lysosomal function (the Chediak-Higashi syndrome).

Authors:  U Lerner; M Ransjö; G T Gustafson
Journal:  Experientia       Date:  1981-07-15

3.  Use of forskolin to study the relationship between cyclic AMP formation and bone resorption in vitro.

Authors:  U H Lerner; B B Fredholm; M Ransjö
Journal:  Biochem J       Date:  1986-12-01       Impact factor: 3.857

4.  Bradykinin stimulates bone resorption and lysosomal-enzyme release in cultured mouse calvaria.

Authors:  G T Gustafson; U Lerner
Journal:  Biochem J       Date:  1984-04-01       Impact factor: 3.857

5.  Isolation of osteoclasts from fetal rat long bones.

Authors:  T J Hefley; P H Stern
Journal:  Calcif Tissue Int       Date:  1982-09       Impact factor: 4.333

6.  Indomethacin inhibits bone resorption in vitro without affecting bone collagen synthesis.

Authors:  U Lerner
Journal:  Agents Actions       Date:  1982-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.